Scimago Institutions Rankings
menu
| Title | Type |  SJR |
H index | Total Docs. (2019) | Total Docs. (3years) | Total Refs. (2019) | Total Cites (3years) | Citable Docs. (3years) | Cites / Doc. (2years) | Ref. / Doc. (2019) | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Nature Reviews Drug Discovery | journal | 7.018 Q1 | 309 | 188 | 786 | 8542 | 7067 | 411 | 17.06 | 45.44 |  |
| 2 | Journal for ImmunoTherapy of Cancer | journal | 4.194 Q1 | 45 | 357 | 350 | 14235 | 3038 | 311 | 9.80 | 39.87 | |
| 3 | Natural Product Reports | journal | 3.421 Q1 | 168 | 111 | 218 | 12134 | 2239 | 205 | 10.35 | 109.32 | |
| 4 | Pharmacology and Therapeutics | journal | 3.348 Q1 | 193 | 149 | 433 | 32417 | 4427 | 433 | 10.31 | 217.56 | |
| 5 | Neuropsychopharmacology | journal | 3.122 Q1 | 214 | 327 | 958 | 17020 | 6024 | 852 | 6.40 | 52.05 | |
| 6 | npj Vaccines | journal | 2.465 Q1 | 15 | 54 | 107 | 2802 | 558 | 99 | 5.83 | 51.89 | |
| 7 | Journal of Antimicrobial Chemotherapy | journal | 2.230 Q1 | 185 | 600 | 1718 | 14665 | 7705 | 1486 | 5.22 | 24.44 | |
| 8 | Emerging Microbes and Infections | journal | 2.212 Q1 | 38 | 172 | 415 | 7686 | 2064 | 334 | 5.83 | 44.69 | |
| 9 | Advanced healthcare materials | journal | 2.135 Q1 | 74 | 353 | 998 | 26597 | 7022 | 953 | 7.47 | 75.35 | |
| 10 | npj Systems Biology and Applications | journal | 2.043 Q1 | 14 | 43 | 99 | 2071 | 442 | 97 | 4.14 | 48.16 | |
| 11 | Environmental Pollution | journal | 1.968 Q1 | 211 | 1627 | 3541 | 98156 | 25893 | 3497 | 7.31 | 60.33 | |
| 12 | Particle and Fibre Toxicology | journal | 1.922 Q1 | 92 | 48 | 169 | 3332 | 1233 | 162 | 7.73 | 69.42 | |
| 13 | Current Opinion in Systems Biology | journal | 1.809 Q1 | 12 | 76 | 193 | 4997 | 484 | 171 | 2.83 | 65.75 | |
| 14 | Journal of Toxicology and Environmental Health - Part B: Critical Reviews | journal | 1.766 Q1 | 78 | 9 | 63 | 1600 | 426 | 58 | 6.13 | 177.78 | |
| 15 | Expert Review of Vaccines | journal | 1.746 Q1 | 81 | 103 | 358 | 9932 | 1377 | 312 | 4.68 | 96.43 | |
| 16 | Expert Opinion on Therapeutic Targets | journal | 1.699 Q1 | 83 | 92 | 320 | 9520 | 1480 | 278 | 5.49 | 103.48 | |
| 17 | International Journal of Neuropsychopharmacology | journal | 1.695 Q1 | 101 | 59 | 381 | 1834 | 1663 | 356 | 4.34 | 31.08 | |
| 18 | Neuropharmacology | journal | 1.638 Q1 | 159 | 408 | 1389 | 31064 | 6279 | 1363 | 4.62 | 76.14 | |
| 19 | Human Genomics | journal | 1.594 Q1 | 50 | 69 | 123 | 1350 | 392 | 117 | 3.06 | 19.57 | |
| 20 | Addictive Behaviors | journal | 1.558 Q1 | 120 | 450 | 997 | 19951 | 3803 | 970 | 4.07 | 44.34 | |
| 21 | Clinical Trials | journal | 1.549 Q1 | 58 | 101 | 258 | 2296 | 587 | 212 | 2.41 | 22.73 | |
| 22 | PharmacoEconomics | journal | 1.453 Q1 | 97 | 134 | 358 | 5599 | 1175 | 304 | 3.61 | 41.78 | |
| 23 | Clinical Pharmacokinetics | journal | 1.417 Q1 | 157 | 141 | 364 | 7744 | 1610 | 331 | 4.76 | 54.92 | |
| 24 | British Journal of Clinical Pharmacology | journal | 1.378 Q1 | 137 | 363 | 925 | 13251 | 3273 | 780 | 4.00 | 36.50 | |
| 25 | F1000Research | journal | 1.357 Q1 | 45 | 777 | 2299 | 32414 | 6079 | 2191 | 2.44 | 41.72 | |
| 26 | Nanotoxicology | journal | 1.340 Q1 | 78 | 87 | 330 | 5741 | 1843 | 318 | 5.31 | 65.99 | |
| 27 | Journal of Nanobiotechnology | journal | 1.335 Q1 | 67 | 126 | 279 | 6926 | 1826 | 269 | 6.94 | 54.97 | |
| 28 | BioDrugs | journal | 1.304 Q1 | 63 | 65 | 159 | 3556 | 724 | 144 | 5.58 | 54.71 | |
| 29 | EPMA Journal | journal | 1.263 Q1 | 29 | 36 | 97 | 2328 | 532 | 93 | 5.53 | 64.67 | |
| 30 | CNS Neuroscience and Therapeutics | journal | 1.241 Q1 | 64 | 152 | 365 | 8346 | 1283 | 303 | 4.28 | 54.91 | |
| 31 | Therapeutic Advances in Neurological Disorders | journal | 1.240 Q1 | 44 | 74 | 161 | 4511 | 705 | 149 | 5.32 | 60.96 | |
| 32 | Pharmaceutical Statistics | journal | 1.223 Q1 | 36 | 69 | 166 | 1949 | 267 | 143 | 1.85 | 28.25 | |
| 33 | Acta Pharmacologica Sinica | journal | 1.195 Q1 | 84 | 184 | 509 | 8750 | 2214 | 493 | 4.72 | 47.55 | |
| 34 | Expert Opinion on Investigational Drugs | journal | 1.180 Q1 | 101 | 103 | 365 | 7933 | 1408 | 338 | 4.77 | 77.02 | |
| 35 | Clinical and Translational Science | journal | 1.175 Q1 | 39 | 92 | 185 | 2659 | 560 | 154 | 3.68 | 28.90 | |
| 36 | Toxicological Sciences | journal | 1.175 Q1 | 175 | 234 | 833 | 11907 | 2952 | 745 | 3.83 | 50.88 | |
| 37 | Drug Discovery Today: Technologies | journal | 1.162 Q1 | 45 | 14 | 105 | 937 | 403 | 94 | 4.11 | 66.93 | |
| 38 | Expert Opinion on Drug Discovery | journal | 1.160 Q1 | 56 | 113 | 319 | 10359 | 1332 | 271 | 5.11 | 91.67 | |
| 39 | Drug Safety | journal | 1.148 Q1 | 120 | 134 | 361 | 7023 | 1138 | 295 | 3.64 | 52.41 | |
| 40 | Critical Reviews in Toxicology | journal | 1.107 Q1 | 107 | 39 | 133 | 6684 | 561 | 116 | 3.81 | 171.38 | |
| 41 | Journal of Exposure Science and Environmental Epidemiology | journal | 1.077 Q1 | 87 | 121 | 228 | 5100 | 816 | 222 | 3.57 | 42.15 | |
| 42 | Drug Delivery | journal | 1.072 Q1 | 57 | 129 | 760 | 5827 | 3670 | 747 | 5.12 | 45.17 | |
| 43 | Expert Opinion on Therapeutic Patents | journal | 1.027 Q1 | 66 | 74 | 295 | 6360 | 1360 | 280 | 5.63 | 85.95 | |
| 44 | Expert Opinion on Drug Delivery | journal | 1.001 Q1 | 98 | 107 | 366 | 11282 | 1745 | 334 | 5.13 | 105.44 | |
| 45 | Pharmacogenomics Journal | journal | 0.981 Q1 | 83 | 96 | 255 | 4811 | 738 | 239 | 2.98 | 50.11 | |
| 46 | Pharmacology Research and Perspectives | journal | 0.953 Q1 | 24 | 95 | 230 | 3628 | 562 | 225 | 2.15 | 38.19 | |
| 47 | Expert Opinion on Drug Metabolism and Toxicology | journal | 0.930 Q1 | 76 | 88 | 380 | 8459 | 1248 | 343 | 3.77 | 96.13 | |
| 48 | Molecular Diagnosis and Therapy | journal | 0.921 Q2 | 38 | 66 | 189 | 5442 | 558 | 180 | 3.36 | 82.45 | |
| 49 | Expert Opinion on Biological Therapy | journal | 0.917 Q1 | 83 | 131 | 445 | 10758 | 1297 | 406 | 3.20 | 82.12 | |
| 50 | Clinical Toxicology | journal | 0.912 Q1 | 91 | 239 | 487 | 5000 | 1145 | 323 | 3.40 | 20.92 | |
Powered by:
Follow us on @ScimagoJR
Scimago Lab, Copyright 2007-2020. Data Source: Scopus®
Download data